According to FutureWise analysis the market for VNA and PACS in 2023 is US$ 3.74 billion, and is expected to reach US$ 6.39 billion by 2031 at a CAGR of 6.90%.
Healthcare organizations are innovating in creating affordable care services and meeting the needs of value-based payments. VNA and PACS enable the healthcare systems for efficient management of medical images, streamlining business and clinical workflows. These methods shall help healthcare providers in improving the treatment quality, reducing costs, increasing efficiency and shifting resources for innovation. Furthermore, increased grants and investments by companies and government bodies in medical imaging plays a crucial role in implementing these imaging technologies, improving a patient’s quality of life, modernizing imaging facilities. For example, the European Investment Bank in November 2017 announced that they will provide a financial assistance of over EUR 25 million to a Berlin-based company, Medneo Group, offering novel imaging diagnostics technology and services. Such investments in the field of medical imaging is primarily responsible for the VNA and PACS market growth.
There has been a surge in the usage of AI in medical imaging. Major market players are developing in-house AI solutions to promote them as integrated or supplementary offerings with their marquee HCIT products. Since 2015, over 40 start-ups developing machine learning and AI-based medical imaging solutions have entered the market. Such a booming demand for AI has aided in the proliferation of the market.